STATE STREET CORP - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 120 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,083,425
+34.8%
2,285,944
-1.0%
0.00%
+100.0%
Q2 2023$25,277,998
+333.3%
2,308,493
+245.0%
0.00%
Q1 2023$5,833,994
+37.5%
669,036
-1.1%
0.00%
Q4 2022$4,241,944
+258.3%
676,546
+100.0%
0.00%
Q3 2022$1,184,000
+10.9%
338,273
-6.6%
0.00%
Q2 2022$1,068,000
-74.7%
362,120
-73.3%
0.00%
Q1 2022$4,224,000
-6.3%
1,358,050
+1.8%
0.00%
Q4 2021$4,509,000
-3.3%
1,333,890
+4.5%
0.00%
Q3 2021$4,661,000
-21.2%
1,276,967
-5.9%
0.00%
Q2 2021$5,917,000
+1.0%
1,357,224
+5.1%
0.00%
Q1 2021$5,860,000
-43.5%
1,290,846
-28.6%
0.00%
-100.0%
Q4 2020$10,380,000
-12.6%
1,808,347
+10.2%
0.00%0.0%
Q3 2020$11,877,000
+140.6%
1,640,514
+16.0%
0.00%
Q2 2020$4,937,000
+134.6%
1,414,471
-0.5%
0.00%
Q1 2020$2,104,000
-23.9%
1,421,566
+0.8%
0.00%
Q4 2019$2,763,000
-65.9%
1,409,914
-10.8%
0.00%
-100.0%
Q3 2019$8,097,000
-29.6%
1,581,453
-1.5%
0.00%0.0%
Q2 2019$11,501,000
-31.5%
1,606,334
+27.0%
0.00%0.0%
Q1 2019$16,796,000
+66.4%
1,264,755
-1.4%
0.00%0.0%
Q4 2018$10,092,000
-30.7%
1,282,395
-2.5%
0.00%0.0%
Q3 2018$14,571,000
-17.8%
1,315,230
-0.5%
0.00%0.0%
Q2 2018$17,734,000
+483.7%
1,321,563
+465.3%
0.00%
Q1 2018$3,038,000
+642.8%
233,790
+425.1%
0.00%
Q4 2017$409,000
+46.6%
44,522
+28.3%
0.00%
Q3 2017$279,00034,7000.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders